ĀÜĄņĀŅĀ×

Nigel Burns is an accomplished professional with extensive experience in consultancy and advisory roles within the life sciences sector. Currently serving as a Partner at Alacrita Consulting since January 2023, Nigel has also been a member of the Business Advisory Board for ProMISā„¢ Neurosciences since 2016 and holds a non-executive director position at Cell Medica. As a consultant and founder of Sweet Spot Therapeutics (Consulting) Ltd, Nigel has played a pivotal role in various organizations. Additionally, Nigel held research associate responsibilities at The University of Manchester and has been involved with numerous science-focused boards, including the CRT Pioneer Fund. An alumnus of both Imperial College London and King's College London, Nigel holds a BSc in Biochemistry and a PhD in Biochemistry.